Berlin - Delayed Quote EUR

BioNTech SE (22UA.BE)

82.40
-2.00
(-2.37%)
As of 8:00:31 AM GMT+2. Market Open.
Advanced Chart
Loading Chart for 22UA.BE
  • Previous Close 84.40
  • Open 82.40
  • Bid 82.85 x --
  • Ask 83.30 x --
  • Day's Range 82.40 - 82.40
  • 52 Week Range 71.70 - 123.00
  • Volume 0
  • Avg. Volume 118
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 22UA.BE

View More
View More

Performance Overview: 22UA.BE

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

22UA.BE
24.26%
MSCI WORLD (^990100-USD-STRD)
3.56%

1-Year Return

22UA.BE
3.17%
MSCI WORLD (^990100-USD-STRD)
10.59%

3-Year Return

22UA.BE
45.23%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

22UA.BE
90.73%
MSCI WORLD (^990100-USD-STRD)
91.20%

Compare To: 22UA.BE

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

22UA.BE
BioNTech SE
82.40
-2.37%
Mkt Cap EUR -
Industry Biotechnology
NVV1.BE
Novavax Inc
5.29
-3.99%
Mkt Cap EUR -
Industry Biotechnology
NVV1.SG
Novavax Inc
5.26
-0.68%
Mkt Cap EUR -
Industry Biotechnology
NVV1.F
Novavax, Inc.
5.56
+4.87%
Mkt Cap EUR 905.117M
Industry Biotechnology
0QF.DE
Moderna, Inc.
21.01
-3.93%
Mkt Cap EUR 8.125B
Industry Biotechnology
IPA
ImmunoPrecise Antibodies Ltd.
0.4890
-1.61%
Mkt Cap 22.379M
Industry Biotechnology
NVAX
Novavax, Inc.
6.25
+4.86%
Mkt Cap 1.012B
Industry Biotechnology

Statistics: 22UA.BE

View More

Valuation Measures

As of 5/14/2025

  • Market Cap

    19.79B

  • Enterprise Value

    5.97B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.39

  • Price/Book (mrq)

    1.07

  • Enterprise Value/Revenue

    2.18

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: 22UA.BE

View More
View More

People Also Watch

22UA.F BioNTech SE
83.10
-2.13%
 
22UA.MU BioNTech SE
82.45
-0.30%
 
22UA.DU BioNTech SE
81.60
-2.51%
 
22UA.HM BioNTech SE
82.70
-0.72%
 
5CV.DE CureVac N.V.
3.0440
+0.59%
 
5CV.F CureVac N.V.
3.0740
+1.86%
 
0QF.F Moderna, Inc.
21.00
-3.25%
 
NVV1.F Novavax, Inc.
5.56
+4.87%
 
BNTXN.MX BioNTech SE
1,810.00
0.00%
 
PFE.DE Pfizer Inc.
20.12
+1.27%
 
GIS.DE Gilead Sciences, Inc.
89.11
+0.07%
 
22UA.DE BioNTech SE
83.30
-0.36%
 
27W.F PowerCell Sweden AB (publ)
2.3420
+1.47%
 
D7G.F Nel ASA
0.1951
-7.10%
 
0QF.BE Moderna Inc
20.88
-3.02%
 
BY6.F BYD Company Limited
48.05
+0.27%